Literature DB >> 31605921

Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis.

Chun-Ta Huang1, Meng-Rui Lee2, Sheng-Yuan Ruan3, Yi-Ju Tsai4, Jann-Yuan Wang5, Chong-Jen Yu3.   

Abstract

BACKGROUND: _The mitogen response in interferon-γ(IFN-γ) release assays(IGRAs) measures IFN-γ after binding to CD2, a surface adhesion marker found on T-cells and NK cells. A lower mitogen response implies either peripheral blood mononuclear cells have fewer adhesion molecules either in absolute numbers or per T-cells, or the pathway from adhesion molecules to IFN-γ production is not functioning well. To date, it remains poorly understood whether the mitogen response is associated with outcomes in tuberculosis patients.
METHODS: _From 2012 to 2017, patients with culture-confirmed tuberculosis were tested for QuantiFERON-TB Gold In-Tube(QFT-GIT). The associations between patient outcomes and QFT-GIT as well as IFN-γ responses to the mitogen were investigated. Outcomes of interest included 1-year mortality after tuberculosis diagnosis and 2-month culture conversion.
RESULTS: _In total, 466 culture-confirmed tuberculosis patients were enrolled and QFT-GIT was positive in 309(66%). Within 1 year of diagnosis, 20(4%) died and notably, 15(11%) out of 137 patients with a lower mitogen response did so. The multivariate Cox model showed that a lower mitogen response (hazard ratio, 8.789; 95% confidence interval, 3.074-25.129) was independently associated with 1-year mortality. Moreover, among 160 patients with smear-positive culture-confirmed pulmonary tuberculosis, multivariate logistic analysis indicated that a lower mitogen response (odds ratio, 3.966; 95% confidence interval, 1.182-13.303) was significantly associated with 2-month culture persistence.
CONCLUSIONS: _This study found that a lower mitogen response was associated with worse 1-year survival in tuberculosis patients and correlated with 2-month culture persistence in patients with sputum smear-positive culture-confirmed tuberculosis. These findings suggest another application of QFT-GIT for prognostication of tuberculosis patients.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Interferon-γ; Interferon-γ release assay; Mortality; Prognosis; Tuberculosis

Year:  2019        PMID: 31605921     DOI: 10.1016/j.rmed.2019.10.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  2 in total

1.  Beyond QuantiFERON-TB Results, the Added Value of a Weak Mitogen Response.

Authors:  Marine Jacquier; Christine Binquet; Catherine Manoha; Sylvain Audia; Anne-Laure Simonet-Lamm; Alice Casenaz; Amadou-Khalilou Sow; Lionel Piroth; Mathieu Blot
Journal:  Front Med (Lausanne)       Date:  2022-05-30

2.  Developmental exposure to low doses of dichlorodiphenyltrichloroethane impairs proliferative response of thymic lymphocytes to Concanavalin A in rats.

Authors:  Nataliya V Yaglova; Elina S Tsomartova; Sergey S Obernikhin; Marina Y Ivanova; Elizaveta V Chereshneva; Svetlana G Muhamedova; Tatiana A Lomanovskaya; Valentin V Yaglov
Journal:  Heliyon       Date:  2020-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.